Cosmos Health (COSM) Cash from Financing Activities (2010 - 2026)
Cosmos Health (COSM) recorded quarterly Cash from Financing Activities of $347627.0 in Q1 2026, down 92.6% on a QoQ basis from $4.7 million in Q4 2025, and down 38.02% year-over-year from $560862.0 in Q1 2025.
Cosmos Health (COSM) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Cosmos Health has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $347627.0 for Q1 2026.
- Quarterly Cash from Financing Activities fell 38.02% year-over-year to $347627.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (up 156.32% YoY) and the FY2025 annual result came in at $14.1 million, up 178.52% from the prior year.
- Cash from Financing Activities fell to $347627.0 in Q1 2026, from $4.7 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $30.6 million in Q4 2022 and troughed at -$184191.0 in Q2 2023.
- A 5-year average of $4.0 million and a median of $1.6 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 3758.08% — and 2023, when it sank 132.96%.
- Tracing COSM's Cash from Financing Activities over 5 years: stood at $30.6 million in 2022, then sank by 85.96% to $4.3 million in 2023, then plunged by 62.26% to $1.6 million in 2024, then jumped by 190.03% to $4.7 million in 2025, then sank by 92.6% to $347627.0 in 2026.
- Business Quant data shows COSM's Cash from Financing Activities at $347627.0 in Q1 2026, $4.7 million in Q4 2025, and $7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 347,627.00 |
| Mar 31, 2026 | 347,627.00 |
| Dec 31, 2025 | 4.70 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 7.19 Mn |
| Sep 30, 2025 | 7.19 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 560,862.00 |
| Mar 31, 2025 | 560,862.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 539,668.00 |
| Jun 30, 2024 | 539,668.00 |
| Mar 31, 2024 | 206,942.00 |
| Mar 31, 2024 | 206,942.00 |
| Dec 31, 2023 | 4.29 Mn |
| Dec 31, 2023 | 4.29 Mn |